New webinar series to help management of respiratory conditions during COVID-19
PCRS is delighted to announce the launch of Wave 1 of a series of new educational webinars for HCPs and patients to help the management of primary care respiratory conditions in light of the current COVID-19 pandemic.
Featuring expert clinicians from PCRS and produced in partnership with AstraZeneca, this series of webinars available on the InterACT Respiratory website tackles some of the key issues and challenges facing practitioners as they seek to provide the best care possible to their patients despite restraints and risks caused by COVID- 19.
Dr Noel Baxter, GP and Policy Lead at PCRS, kicks off the webinar series with a range of general COVID – 19 Advice for Respiratory Clinicians, including the impact of the pandemic on treatment, safe ways of working, and the supply of respiratory medicines.
GP Dr Steve Holmes from Park Medical Practice in Shepton Mallet discusses Severe Asthma: the prevalence, burden and definition of the disease; pragmatic advice when assessing patients; when to consider a referral; and, special considerations for asthma patients during the Covid 19 pandemic.
Nurse Practitioner, Carol Stonham MBE (Gloucestershire CCG), and Chair of PCRS Executive Committee, discusses the challenges, aims and approaches to good Asthma Management, the importance of reducing reliance on reliever inhalers and working with patients as partners to help reduce asthma admissions to hospital.
And finally, as more of us turn to the virtual world and technology to see us through, Dr Vincent McGovern, GP, Belfast, Bangor and Hillsborough and Ruth McArthur, Practice Nurse in East Kilbride, talk about Virtual Asthma Clinical Reviews including, how to asses asthma remotely, using tools such as RCP and ACT questionnaire, managing asthma using the SIMPLES approach and developing asthma action plans.
Lung disease has not gone away, with 115 000 deaths from lung disease every year, 1500 people diagnosed with lung disease each day, and with the full impact of COVID 19 still yet to be fully understood, it is now more important than ever to build our expertise, toolkits and understanding of the effective treatment of the disease.
PCRS and Astra Zeneca plan to launch Wave 2 of the educational webinar series in the coming weeks.
Notes:
InterACT is a unique medical education platform developed by AstraZeneca in partnership with disease area experts. InterACT aims to equip healthcare professionals and their patients with high quality, accredited educational resources which enables them to confidently manage and improve outcomes for chronic diseases.
The series of Respiratory webinars has been funded by Astra Zeneca UK Ltd. All clinical content has been written, reviewed and approved independently by PCRS.